Ror2 expression in squamous cell carcinoma and epithelial dysplasia of the oral cavity

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 107, Issue 3, 2009, Pages 398-406

  Kobayashi, Masaki ^a   Shibuya, Yasuyuki ^b   Takeuchi, Junichiro ^b   Murata, Maho ^b   Suzuki, Hiroaki ^b   Yokoo, Satoshi ^b   Umeda, Masahiro ^b   Minami, Yasuhiro ^b   Komori, Takahide ^b  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; CYCLINE; KI 67 ANTIGEN; PROTEIN P53; PROTEIN TYROSINE KINASE; ROR2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CASE CONTROL STUDY; CELL MEMBRANE; CHEMISTRY; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PRECANCER; ROUGH ENDOPLASMIC RETICULUM; SQUAMOUS CELL CARCINOMA; TONGUE TUMOR; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL MEMBRANE; ENDOPLASMIC RETICULUM, ROUGH; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; TONGUE NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 59649083204     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2008.08.018     Document Type: Article

References (38)

1. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 103 (2000) 211-225
2. Masiakowski P., and Carroll R.D. A novel family of cell surface receptors with tyrosine kinase-like domain. J Biol Chem 267 (1992) 26181-26190
3. Patton M.A., and Afzal A.R. Robinow syndrome. J Med Genet 39 (2002) 305-310
4. Oldridge M., Fortuna A.M., Maringa M., Propping P., Mansour S., Pollitt C., et al. Dominant mutations in Ror2, encoding an orphan receptor tyrosine kinase, cause brachydactyly type B. Nature Genet 24 (2000) 275-278
5. Schwabe G.C., Tinschert S., Buschow C., Meinecke P., Wolff G., Gillessen-Kaesbach G., et al. Distinct mutations in the receptor tyrosine kinase gene Ror2 cause brachydactyly type B. Am J Hum Genet 67 (2000) 822-831
6. Nusse R., and Varmus H.E. Wnt genes. Cell 69 (1992) 1073-1087
7. Oishi I., Suzuki H., Onishi N., Takada R., Kani S., Ohkawara B., et al. The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signaling pathway. Genes Cells 8 (2003) 645-654
8. Katoh M. Comparative genomics on ROR1 and ROR2 orthologs. Oncol Rep 14 (2005) 1381-1384
9. Nishita M., Yoo S.K., Nomachi A., Kani S., Sougawa N., Ohta Y., et al. Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration. J Cell Boil 175 (2006) 555-562
10. Iozzo R.V., Eichstetter I., and Danielson K.G. Aberrant expression of the growth factor Wnt-5A in human malignancy. Cancer Res 55 (1995) 3495-3499
11. Katoh M. WNT/PCP signaling pathway and human cancer. Oncol Rep 14 (2005) 1583-1588
12. Huang C.L., Liu D., Nakano J., Ishikawa S., Kontani K., Yokomise H., et al. Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor-an expression in non-small-cell lung cancer. J Clin Oncol 23 (2005) 8765-8773
13. Kurayoshi M., Oue N., Yamamoto H., Kishida M., Inoue A., Asahara T., et al. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 66 (2006) 10439-10448
14. Parkin D.M., Loara E., and Muir C.S. Estimates of the world wide frequency of sixteen major cancers in 1980. Int J Cancer 41 (1988) 184-197
15. Young M.R., Neville B.W., Chi A.C., Lathers D.M., Boyd Gillespie M., and Day T.A. Oral premalignant lesions induce immune reactivity to both premalignant oral lesions and head and neck squamous cell carcinoma. Cancer Immunol Immunother 56 (2007) 1077-1086
16. Oishi I., Takeuchi S., Hashimoto R., Nagabukuro A., Ueda T., Liu Z.J., et al. Spatio-temporally regulated expression of receptor tyrosine kinases, mRor1, mRor2, during mouse development: implications in development and function of the nervous system. Genes Cells 4 (1999) 41-56
17. Kani S., Oishi I., Yamamoto H., Yoda A., Suzuki H., Nomachi A., et al. The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase Iepsilon. J Biol Chem 279 (2004) 50102-50109
18. Murata M., Shibuya Y., Munemoto S., Takeuchi J., Kobayashi M., Suzuki H., et al. Ultrastructural localization of alpha E-catenin in the rat sciatic nerve. Kobe J Med Sci 52 (2006) 77-84
19. Shibuya Y., Yasuda H., Tomatsuri M., Mizoguchi A., Takeichi M., Shimada K., et al. Alpha N-catenin expression in the normal and regenerating chick sciatic nerve. J Neurocytol 25 (1996) 615-624
20. Lim S.C., Zhang S., Ishii G., Endoh Y., Kodama K., Miyamoto S., et al. Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue. Clin Cancer Res 10 (2004) 166-172
21. Yoda A., Oishi I., and Minami Y. Expression and function of the Ror-family receptor tyrosine kinases during development: lessons from genetic analyses of nematodes, mice, and humans. J Recept Signal Transduct Res 13 (2003) 1-15
22. Chen W., ten Berge D., Brown J., Ahn S., Hu L.A., Miller W.E., et al. Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4. Science 301 (2003) 1391-1394
23. Blitzer J.T., and Nusse R. A critical role for endocytosis in Wnt signaling. BMC Cell Biol 7 (2003) 28
24. Yamanaka H., Moriguchi T., Masuyama N., Kusakabe M., Hanafusa H., Takada R., et al. JNK functions in the non-canonical Wnt pathway to regulate convergent extension movements in vertebrates. EMBO Rep 3 (2002) 69-75
25. Topol L., Jiang X., Choi H., Garrett-Beal L., Carolan P.J., and Yang Y. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 162 (2003) 899-908
26. Mikels A.J., and Nusse R. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol 4 (2006) e115
27. MacLeod R.J., Hayes M., and Pacheco I. Wnt5a secretion stimulated by the extracellular calcium-sensing receptor inhibits defective Wnt signaling in colon cancer cells. Am J Physiol Gastrointest Liver Physiol 293 (2007) G403-G411
28. van Noort M., and Clevers H. TCF transcription factors, mediators of Wnt-signaling in development and cancer. Dev Biol 244 (2002) 1-8
29. Schambony A., and Wedlich D. Wnt-5A/Ror2 regulate expression of XPAPC through an alternative noncanonical signaling pathway. Dev Cell 12 (2007) 779-792
30. Paganoni S., and Ferreira A. Neurite extension in central neurons: a novel role for the receptor tyrosine kinases Ror1 and Ror2. J Cell Sci 118 (2005) 433-446
31. Hikasa H., Shibata M., Hiratani I., and Taira M. The Xenopus receptor tyrosine kinase Xror2 modulates morphogenetic movements of the axial mesoderm and neuroectoderm via Wnt signaling. Development 129 (2002) 5227-5239
32. Garcia R.L., Coltrera M.D., and Gown A.M. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol 134 (1989) 733-739
33. Gerdes J., Lemke H., Baisch H., Wacker H.H., Schwab U., and Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki67. J Immunol 133 (1984) 1710-1715
34. Nigro J.M., Baker S.J., Preisinger A.C., Jessup J.M., Hostetter R., Cleary K., et al. Mutations in the p53 gene occur in diverse human tumour types. Nature 342 (1989) 705-708
35. Lan H.A., Zain R.B., Saitoh M., Muramatsu Y., Shrestha P., and Mori M. Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa-a marker for poor tumor differentiation, increasing nuclear atypia and invasiveness?. Anticancer Res 16 (1996) 3059-3065
36. Cruz I.B., Snijders P.J., Meijer C.J., Braakhuis B.J., Snow G.B., Walboomers J.M., et al. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol 184 (1998) 360-368
37. Schoelch M.L., Regezi J.A., Dekker N.P., Ng I.O., McMillan A., Ziober B.L., et al. Cell cycle proteins and the development of oral squamous cell carcinoma. Oral Oncol 35 (1999) 333-342
38. Abbas N.F., Labib El-Sharkawy S., Abbas E.A., and Abdel Monem El-Shaer M. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 (2007) 385-390